![Mark Bonyhadi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bonyhadi
No más puestos en curso
Perfil
Mark L.
Bonyhadi served as the Chairman of the American Society of Gene & Cell Therapy.
He was the Director-Global Business Development at Life Technologies Ltd. from 2006 to 2013.
Dr. Bonyhadi also worked as an Independent Director at TC Biopharm (Holdings) Plc from 2022 to 2024.
Prior to that, he was the Vice President-Research & Development at Xcyte Therapies, Inc. from 1997 to 2006.
From 2013 to 2018, he held the position of Vice President-Research & Head-Academic Affairs at Juno Therapeutics, Inc. Dr. Bonyhadi was also a Senior Scientist at Systemix, Inc. He served as a Senior Advisor at Qiming US Ventures Management, LLC from 2018 to 2022.
Dr. Bonyhadi obtained his undergraduate degree from The Reed Institute in 1982 and his doctorate degree from the University of California, Berkeley in 1990.
Antiguos cargos conocidos de Mark Bonyhadi.
| Empresas | Cargo | Fin |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Director/Miembro de la Junta | 26/06/2024 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultor / Asesor | 31/12/2022 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Director Técnico/Científico/I+D | 12/10/2021 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/01/2018 |
Life Technologies Ltd.
 Life Technologies Ltd. BiotechnologyHealth Technology Operates as a global biotechnology tools company | Corporate Officer/Principal | 01/01/2013 |
Formación de Mark Bonyhadi.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
82
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Xcyte Therapies, Inc.
 Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Operates as a global biotechnology tools company | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
TC Biopharm (Holdings) Plc
 TC Biopharm (Holdings) Plc BiotechnologyHealth Technology Operates as a holding company through it's subsidiaries develops clinical-stage cell therapies | Health Technology |
- Bolsa de valores
- Insiders
- Mark Bonyhadi
